The lancet oncology
-
The lancet oncology · Jul 2022
Multicenter StudyCatastrophic expenditure and treatment delivery outcomes in patients with colorectal cancer in India: a prospective, multicentre cohort study.
Little is known about the factors preventing patients with colorectal cancer in India from receiving the treatment they need to reach the best oncological outcomes. Patients often struggle to pay for cancer care, possibly leading to treatment dropout. The aim of this study was to assess treatment adherence and catastrophic expenditure rates in a cohort of patients with colorectal cancer in India. ⋯ National Institute for Health Research Global Health Research Unit Grant (NIHR 16.136.79) with aid from the UK Government to support global health research.
-
The lancet oncology · Jul 2022
Availability of essential medicines for children with cancer in Sri Lanka: a prospective cohort study.
The WHO Model List of Essential Medicines for children (2019 version) contains 39 antineoplastic and supportive medicines deemed essential for the successful treatment of children with cancer. The availability of these medicines varies across countries, but most reports are retrospective or short term. This study tracked the availability of these medicines in Sri Lanka's only treatment centre for childhood cancer, the National Cancer Institute of Sri Lanka, over 1 year, and examined initial mitigation strategies and implications. ⋯ None.
-
The lancet oncology · Jul 2022
Factors affecting acceptance of palliative care in mainland China: a national cross-sectional study.
China ranks 53rd in the list of 81 countries included in the Quality of Death and Dying Index 2021. Cancer is one of the leading causes of death in China. Although the country is highly burdened with cancer, with 4·5 million new diagnoses and more than 3 million cancer deaths in 2020 alone, palliative care services in mainland China are extremely scarce. The aim of this study was to investigate the attitudes of people towards palliative and hospice care, and to analyse the associations between attitudes and potential explanatory variables. ⋯ The scientific research project of Shaanxi Provincial Education Department, 2021 (grant 21JZ017), and Youth Project of Key Research Bases of Philosophy and Social Sciences in the Sichuan Province (grant YF22-Q13).
-
The lancet oncology · Jul 2022
Prognostic factors in curative intent stage I lung adenocarcinoma: a retrospective hospital-based cohort study.
Radiotherapy or surgery, depending on hospital specialisation status (ie, High Complexity Centres in Oncology [HCCO; hospitals with infrastructure, technology, physical facilities, equipment, and human resources suitable for highly complex specialised assistance], or Partial Hospital Complexity Centres in Oncology [PHCCO; hospitals with infrastructures and specialisation similar to that of HCCOs, but doing diagnosis and treatment for common cancers only], as per nomenclature used in Brazil), can increase overall survival in patients diagnosed with lung adenocarcinoma. However, many patients do not accept surgery because of comorbidities and personal preferences. In addition, the long time between diagnosis and treatment and the qualification of the hospital specialisation status might affect the outcomes for patients with lung adenocarcinoma. The aim of this study was to evaluate prognostic factors of overall survival in patients with stage I lung cancer adenocarcinoma diagnosed in the state of São Paulo, Brazil. ⋯ Oncocentro Foundation and Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
-
The lancet oncology · Jul 2022
Radiotherapy and cancer status in Latin America: economic analysis of investment opportunities up to 2030.
Timely access to radiotherapy treatments for cancer in Latin America is hindered by substantial delays in investment. We herein report on the current incidence of the ten most frequent malignancies and on radiotherapy-related logistics across Latin America with the objective of identifying resource gaps and facilitate the planning of health-care investments up to 2030. ⋯ None.